학술논문
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study
Document Type
Article
Author
Source
In Clinical Lung Cancer May 2021 22(3):e395-e404
Subject
Language
ISSN
1525-7304